GlassScriptPhysician profile
Amirhossein Mahfoozi
NPI 1205095635
$23,133.95
in general payments reported to CMS, 2019-2025
12 companies · $4,628 in 2025
The $4,628 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,007 · 2021: $3,493 · 2022: $568 · 2023: $209 · 2024: $75.13 · 2025: $4,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,050 · Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,050.23 |
| Food and Beverage | $861.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,737.46 | 2019-2025 | Da Vinci Surgical System |
| Pinnacle Biologics, INC | $651.89 | 2019-2024 | Photofrin |
| Medtronic, INC. | $595.07 | 2023-2025 | Signia |
| Csa Medical, INC | $412.17 | 2019 | |
| Covidien LP | $320.20 | 2019 | |
| Acell, INC. | $124.08 | 2019 | |
| Ethicon US, LLC | $100.17 | 2019-2025 | Stratafix |
| Atricure, INC. | $53.53 | 2019 | |
| Baxter Healthcare | $51.07 | 2024 | Preveleak |
| Zimmer Biomet Holdings, INC. | $42.69 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $32.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amirhossein Mahfoozi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.